Ping Liao

21PUBLICATIONS

90CO-AUTHORS

Molecular targetsHaematologyEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 06, 2026

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

|Mar 04, 2024

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Jai N Patel, Chen Jiang, Kouros Owzar

|Feb 22, 2024

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.

Sharon P Shriver, Devon Adams, Brittany Avin McKelvey

|Jan 15, 2024

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer

|Jun 28, 2023

Pharmacogenomic Analyses Implicate B Cell Developmental Status and <i>MKL1</i> as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy.

George W Small, Farida S Akhtari, Adrian J Green

|May 27, 2023

<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients.

Ricardo D Gonzalez, George W Small, Adrian J Green

Pageof 4

Frequent Collaborators

Todd C Knepper

George W Small

Ricardo D Gonzalez

David M Reif

Julia Quintanhila

Adrian J Green

Xiao-Ping Chen

Ke-Ke Liu

Shu-Sen Sun

Ya-Min Huang

Frequent Collaborators

Todd C Knepper

George W Small

Ricardo D Gonzalez

David M Reif